A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Issue 3 (3rd March 2016) - Wartman, Lukas D.; Fiala, Mark A.; Fletcher, Theresa; Hawkins, Emily R.; Cashen, Amanda; DiPersio, John F.; Jacoby, Meagan A.; Stockerl-Goldstein, Keith E.; Pusic, Iskra; Uy, Geoffrey L.; Westervelt, Peter; Vij, Ravi